Effects of Recursive Self-feedback on Speech Production in Aphasia
Launched by UNIVERSITY OF SOUTH FLORIDA · Mar 20, 2024
Trial Information
Current as of August 20, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how a technique called recursive self-feedback can help improve speech in stroke survivors who have difficulty speaking, a condition known as aphasia. The main goal is to find out if these individuals can use feedback from their own speech to enhance their ability to speak spontaneously. Participants will take part in various language and thinking tasks, and then they will use tablets and headphones to listen to recordings of their own speech while responding to prompts. They will practice this multiple times to help correct any mistakes they make.
To be eligible for the study, participants must be at least six months post-stroke affecting the left side of the brain and be dominant English speakers. They should not have other conditions that cause speech problems, such as Parkinson's disease, or have severe cognitive impairments. The study will compare two different ways of providing feedback to see which might be more effective for improving speech. Importantly, all treatments will be provided at no cost to participants. The trial is not yet recruiting, but it aims to offer valuable insights into improving communication for those affected by aphasia after a stroke.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 6 months post left hemisphere stroke
- • Aphasia due to left hemisphere stroke
- • Dominant English speaker
- Exclusion Criteria:
- • Speech-language deficits due to neurological insults such as Parkinson's disease, neurodegenerative conditions etc.
- • Uncorrected sensory impairments.
- • Language comprehension impairment.
- • Severe cognitive impairment.
About University Of South Florida
The University of South Florida (USF) is a leading research institution dedicated to advancing health and science through innovative clinical trials. With a strong commitment to improving patient outcomes, USF leverages its diverse faculty expertise and state-of-the-art facilities to conduct rigorous and ethically sound research. The university fosters collaboration across disciplines, engaging in partnerships that enhance the translation of scientific discoveries into effective therapeutic interventions. USF's clinical trial programs are designed to address pressing health challenges and contribute to the body of knowledge in various medical fields, ultimately aiming to benefit communities and improve public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Gerald C. Imaezue, PhD
Principal Investigator
University of South Florida
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported